Orchid Pharma Ltd.

•

orchidpharma.comBSE: 524372NSE: ORCHPHARMA

Market Cap₹ 5,717 Cr.

Current Price

High / Low₹ 1,133 / 480

Stock P/E659.7

Book Value₹ 217

Price to Book3.11

Dividend Yield0.00 %

ROCE8.0 %

ROE7.9 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company comfortably covers its interest (7.4x coverage)
Company maintains a comfortable, low leverage position

CONS

Recent results are weak - TTM profit is down 179.6% versus prior year
A large part of profit comes from other income (36.0% of PBT)
Company has a low return on capital employed of 8.8%
Company has a low return on equity of 8.8% over last 3 years
Effective tax rate is unusually low at -0.2% - earnings may be flattered
Equity base is being diluted - shares outstanding up 24.3%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ORCHPHARMA	954.70	659.73	5717.24	0.00	3.22	-78.38	304.17	75.89	8.05	4.82

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	183	199	221	217	244	223	217	237	173	194	207	238	304
	161	175	185	188	212	192	191	209	159	195	206	211	303
Operating Profit	22	23	35	29	32	30	26	28	14	-1	2	27	1
OPM %	12.10%	11.73%	16.04%	13.32%	13.30%	13.62%	12.13%	11.79%	8.20%	-0.76%	0.76%	11.31%	0.27%
	2	8	8	13	8	8	8	4	11	11	-2	8	2
Interest	6	4	4	3	4	3	4	4	3	4	3	3	2
Depreciation	8	8	9	8	8	9	9	9	9	9	9	9	11
Profit before Tax	11	20	30	30	28	26	22	19	14	-3	-12	23	3
Tax %	0.00%	0.00%	0.00%	-10.27%	-0.53%	0.00%	0.00%	-0.21%	0.00%	-0.00%	-0.00%	0.00%	2.18%
Net Profit	0	0	0	0	29	27	21	22	15	-57	-13	24	3
	1.85	4.30	6.18	6.81	5.79	5.37	4.10	4.40	2.94	-1.13	-2.49	4.69	0.54

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	873	797	683	600	484	450	560	666	819	922	943
	703	709	659	612	454	399	505	582	709	811	915
Operating Profit	171	87	24	-12	30	51	55	84	111	111	28
OPM %	19.55%	10.94%	3.56%	-1.97%	6.24%	11.26%	9.75%	12.66%	13.52%	12.00%	2.95%
	-28	-154	20	218	24	15	9	59	31	34	19
Interest	294	331	310	7	6	52	33	33	17	15	12
Depreciation	145	141	133	130	118	109	87	55	33	35	38
Profit before Tax	-296	-539	-399	69	-70	-95	-57	55	92	96	11
Tax %	5.82%	8.92%	11.58%	0.00%	-0.00%	-0.00%	-0.00%	0.00%	-3.39%	-0.20%	0.68%
Net Profit	-279	-490	-353	69	-70	-95	-57	55	95	96	11
EPS	-32.07	-55.13	-39.65	7.80	-14.75	-28.55	-0.48	11.35	18.17	19.65	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: -6%
5 Years:: 14%
3 Years:: 18%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: 19%
3 Years:: 19%
1 Year:: 32%

RETURN ON EQUITY

10 Years:: -37%
5 Years:: 1%
3 Years:: 9%
Last Year:: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	89	89	89	89	41	41	41	41	51	51
	-40	-477	-881	-793	725	612	607	648	1,119	1,217
	3,264	3,203	3,533	3,404	566	453	268	331	135	174
Trade Payables	374	425	359	302	102	110	168	174	230	222
	174	118	26	75	26	22	28	31	20	24
Total Liabilities	3,862	3,358	3,125	3,077	1,460	1,237	1,111	1,225	1,554	1,688
	1,637	1,497	1,386	1,256	858	670	584	573	620	633
Capital Work in Progress	265	274	257	264	15	7	10	46	16	64
	1	1	1	0	0	15	45	44	46	50
	242	211	194	170	142	153	173	229	264	326
	0	0	0	0	0	0	0	0	196	242
Cash & Bank	315	257	306	326	174	20	8	31	267	180
	1,402	1,118	982	1,061	271	371	291	302	145	193
Total Assets	3,862	3,358	3,125	3,077	1,460	1,237	1,111	1,225	1,554	1,688

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	212	317	16	16	70	19	94	19	126	19
Cash from Investing	-1	-9	-28	45	167	67	113	-31	-312	-27
Cash from Financing	-286	-366	33	-0	-250	-165	-217	31	167	25
	-76	-58	15	57	-2	-74	-11	18	-19	18

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-31.37	-55.13	-39.65	7.80	-32.11	-28.55	-0.48	11.35	18.17	19.65
Book Value (₹)	5.51	-43.58	-89.00	-79.14	187.67	159.96	158.61	168.72	230.58	249.86
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	-15.04	-39.28	-24.67	22.41	11.82	3.35	7.38	26.96	25.30	25.69
PROFITABILITY
Operating Margin %	22.14%	13.17%	6.49%	0.85%	11.26%	14.64%	11.36%	15.58%	13.52%	12.00%
Net Margin %	-31.57%	-60.75%	-51.29%	11.57%	-14.41%	-21.16%	-10.17%	8.30%	11.60%	10.39%
ROE %	-147.51%	0.00%	0.00%	0.00%	-225.00%	-13.43%	-8.75%	8.27%	10.23%	7.86%
ROCE %	-0.06%	-6.93%	-3.46%	3.08%	-3.29%	-3.53%	-2.32%	9.11%	9.35%	8.05%
	-7.05%	-13.59%	-10.88%	2.24%	-3.07%	-7.06%	-4.85%	4.73%	6.84%	5.91%
EFFICIENCY
Debtor Days	117	116	86	73	71	83	100	106	91	87
Inventory Days	102	102	107	111	117	119	106	110	110	117
Payable Days	312	371	408	417	363	169	162	162	152	151
	-93	-152	-215	-233	-174	33	44	53	49	52
FINANCIAL HEALTH
Debt to Equity (x)	65.54x	-8.01x	-4.04x	-4.59x	0.74x	0.69x	0.41x	0.48x	0.12x	0.14x
Interest Coverage (x)	-0.01x	-0.63x	-0.29x	11.38x	-10.19x	-0.82x	-0.70x	2.68x	6.49x	7.40x
	0.94x	0.57x	0.34x	0.33x	3.25x	3.02x	1.60x	1.35x	3.04x	2.83x
GROWTH
Revenue Growth %	-49.99%	-8.81%	-14.25%	-12.15%	-19.36%	-6.97%	24.33%	19.00%	23.05%	12.52%
Operating Profit Growth %	-45.60%	-45.68%	-58.04%	-88.54%	965.63%	20.95%	-3.48%	63.14%	36.82%	2.20%
Net Profit Growth %	-41.58%	-75.73%	28.08%	119.68%	-200.41%	-36.67%	40.26%	197.10%	72.07%	0.73%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	60.13%	8.13%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	57.52x	39.54x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	4.53x	3.11x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	36.42x	27.13x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84
	1.42	1.94	2.53	2.69	1.39	1.56	1.17	0.87	0.80
	18.93	18.30	19.00	20.10	19.43	19.04	19.39	20.24	20.75
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public	9.81	9.93	8.64	7.38	9.34	9.57	9.60	9.05	8.61

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Change in Management

2026-09-03 - Orchid Pharma Limited has informed the Exchange about appointment of cost auditor and change in designation of a Director.

2026-09-03

Outcome of Board Meeting

2026-09-03 - Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

2026-08-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-24 - Orchid Pharma Limited has informed the Exchange about Transcript

2026-08-21

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-21 - Orchid Pharma Limited has informed the Exchange about Link of Recording

2026-08-20

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-20 - Orchid Pharma Limited has informed the Exchange about Presentation

2026-08-17

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Orchid Pharma Limited has informed the Exchange about Schedule of meet

2026-08-14

Monitoring Agency Report

2026-08-14 - Monitoring Agency Report for the Ouarter-I of Financial Year 2026-27, ended on June 30, 2026- Orchid Pharma Limited ("the Company")

2026-08-14

Outcome of Board Meeting

2026-08-14 - Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

2026-08-14

Outcome of Board Meeting

2026-08-14 - Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

News

Recent coverage and analyst commentary for ORCHPHARMA

Loading news…

🤖

AI Stock Analyst

Orchid Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

3620.70

2139.42

20263.10

1191.00

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

ORCHPHARMA

954.70

659.73

5717.24

0.00

3.22

-78.38

304.17

75.89

8.05

4.82

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

183

199

221

217

244

223

217

237

173

194

207

238

304

161

175

185

188

212

192

191

209

159

195

206

211

303

Operating Profit

-1

OPM %

12.10%

11.73%

16.04%

13.32%

13.30%

13.62%

12.13%

11.79%

8.20%

-0.76%

0.76%

11.31%

0.27%

-2

Interest

Depreciation

Profit before Tax

-3

-12

Tax %

0.00%

-10.27%

-0.53%

0.00%

-0.21%

0.00%

-0.00%

0.00%

2.18%

Net Profit

-57

-13

1.85

4.30

6.18

6.81

5.79

5.37

4.10

4.40

2.94

-1.13

-2.49

4.69

0.54

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

873

797

683

600

484

450

560

666

819

922

943

703

709

659

612

454

399

505

582

709

811

915

Operating Profit

171

-12

111

OPM %

19.55%

10.94%

3.56%

-1.97%

6.24%

11.26%

9.75%

12.66%

13.52%

12.00%

2.95%

-28

-154

218

Interest

294

331

310

Depreciation

145

141

133

130

118

109

Profit before Tax

-296

-539

-399

-70

-95

-57

Tax %

5.82%

8.92%

11.58%

0.00%

-0.00%

0.00%

-3.39%

-0.20%

0.68%

Net Profit

-279

-490

-353

-70

-95

-57

EPS

-32.07

-55.13

-39.65

7.80

-14.75

-28.55

-0.48

11.35

18.17

19.65

—

Dividend Payout %

0.00%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

-40

-477

-881

-793

725

612

607

648

1,119

1,217

3,264

3,203

3,533

3,404

566

453

268

331

135

174

Trade Payables

374

425

359

302

102

110

168

174

230

222

174

118

Total Liabilities

3,862

3,358

3,125

3,077

1,460

1,237

1,111

1,225

1,554

1,688

1,637

1,497

1,386

1,256

858

670

584

573

620

633

Capital Work in Progress

265

274

257

264

242

211

194

170

142

153

173

229

264

326

196

242

Cash & Bank

315

257

306

326

174

267

180

1,402

1,118

982

1,061

271

371

291

302

145

193

Total Assets

3,862

3,358

3,125

3,077

1,460

1,237

1,111

1,225

1,554

1,688

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

212

317

126

Cash from Investing

-1

-9

-28

167

113

-31

-312

-27

Cash from Financing

-286

-366

-0

-250

-165

-217

167

-76

-58

-2

-74

-11

-19

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

-31.37

-55.13

-39.65

7.80

-32.11

-28.55

-0.48

11.35

18.17

19.65

Book Value (₹)

5.51

-43.58

-89.00

-79.14

187.67

159.96

158.61

168.72

230.58

249.86

Dividend per Share (₹)

0.00

Cash EPS (₹)

-15.04

-39.28

-24.67

22.41

11.82

3.35

7.38

26.96

25.30

25.69

PROFITABILITY

Operating Margin %

22.14%

13.17%

6.49%

0.85%

11.26%

14.64%

11.36%

15.58%

13.52%

12.00%

Net Margin %

-31.57%

-60.75%

-51.29%

11.57%

-14.41%

-21.16%

-10.17%

8.30%

11.60%

10.39%

ROE %

-147.51%

0.00%

-225.00%

-13.43%

-8.75%

8.27%

10.23%

7.86%

ROCE %

-0.06%

-6.93%

-3.46%

3.08%

-3.29%

-3.53%

-2.32%

9.11%

9.35%

8.05%

-7.05%

-13.59%

-10.88%

2.24%

-3.07%

-7.06%

-4.85%

4.73%

6.84%

5.91%

EFFICIENCY

Debtor Days

117

116

100

106

Inventory Days

102

107

111

117

119

106

110

117

Payable Days

312

371

408

417

363

169

162

152

151

-93

-152

-215

-233

-174

FINANCIAL HEALTH

Debt to Equity (x)

65.54x

-8.01x

-4.04x

-4.59x

0.74x

0.69x

0.41x

0.48x

0.12x

0.14x

Interest Coverage (x)

-0.01x

-0.63x

-0.29x

11.38x

-10.19x

-0.82x

-0.70x

2.68x

6.49x

7.40x

0.94x

0.57x

0.34x

0.33x

3.25x

3.02x

1.60x

1.35x

3.04x

2.83x

GROWTH

Revenue Growth %

-49.99%

-8.81%

-14.25%

-12.15%

-19.36%

-6.97%

24.33%

19.00%

23.05%

12.52%

Operating Profit Growth %

-45.60%

-45.68%

-58.04%

-88.54%

965.63%

20.95%

-3.48%

63.14%

36.82%

2.20%

Net Profit Growth %

-41.58%

-75.73%

28.08%

119.68%

-200.41%

-36.67%

40.26%

197.10%

72.07%

0.73%

0.00%

60.13%

8.13%

VALUATION

P/E (x)

0.00x

57.52x

39.54x

P/B (x)

0.00x

4.53x

3.11x

Dividend Yield %

0.00%

0.00x

36.42x

27.13x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

69.84

1.42

1.94

2.53

2.69

1.39

1.56

1.17

0.87

0.80

18.93

18.30

19.00

20.10

19.43

19.04

19.39

20.24

20.75

Government

0.00

Public

9.81

9.93

8.64

7.38

9.34

9.57

9.60

9.05

8.61

Orchid Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Orchid Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI